Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thalidomide analogs and PDE4 inhibition

G W Muller1, M G Shire, L M Wong

  • 1Celgene Corporation, Warren, NJ 07059 USA.

Bioorganic & Medicinal Chemistry Letters
|January 5, 1999
PubMed
Summary

New thalidomide analogs, N-Phthaloyl 3-amino-3-arylpropionic acids, effectively inhibit tumor necrosis factor-alpha (TNF-α) and phosphodiesterase 4 (PDE4). These findings suggest potential therapeutic applications for these novel compounds.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating Diagnostic Delays and Late Endocrine Sequelae in Children With Intracranial Germ Cell Tumors: A Territory-Wide Population-Based Study.

Pediatric blood & cancer·2025
Same author

Volumetric measurement to evaluate treatment response to induction chemotherapy on MRI outperformed RECIST guideline in outcome prediction in advanced nasopharyngeal carcinoma.

ESMO open·2024
Same author

Glycaemic control and microvascular complications among paediatric type 2 diabetes mellitus patients in Hong Kong at 2 years after diagnosis.

Hong Kong medical journal = Xianggang yi xue za zhi·2024
Same author

Ovarian sex cord stromal tumor with annular tubules in a 7-year-old child: A case report.

Gynecologic oncology reports·2019
Same author

First Report of the Causal Agent of Huanglongbing ("Candidatus Liberibacter asiaticus") in Brazil.

Plant disease·2019
Same author

Evaluation of models predicting insignificant prostate cancer to select men for active surveillance of prostate cancer.

Prostate cancer and prostatic diseases·2015

Area of Science:

  • Medicinal Chemistry
  • Immunology
  • Pharmacology

Background:

  • Thalidomide analogs have shown therapeutic potential.
  • Tumor necrosis factor-alpha (TNF-α) is a key inflammatory cytokine.
  • Phosphodiesterase 4 (PDE4) is a target for inflammatory diseases.

Purpose of the Study:

  • To synthesize and characterize novel N-Phthaloyl 3-amino-3-arylpropionic acid analogs.
  • To evaluate the inhibitory activity of these analogs against TNF-α.
  • To assess the inhibitory potential against PDE4.

Main Methods:

  • Chemical synthesis of N-Phthaloyl 3-amino-3-arylpropionic acid derivatives.
  • In vitro assays to measure TNF-α inhibition.
  • Enzyme inhibition assays for PDE4 activity.

Related Experiment Videos

Main Results:

  • The synthesized compounds demonstrated potent inhibition of TNF-α.
  • These analogs were also identified as potent inhibitors of PDE4.
  • Structure-activity relationships were explored.

Conclusions:

  • N-Phthaloyl 3-amino-3-arylpropionic acid analogs represent a promising class of compounds.
  • Dual inhibition of TNF-α and PDE4 may offer therapeutic advantages.
  • Further investigation is warranted for potential anti-inflammatory applications.